Inventor · disambiguated record
Andrew Stamford
Also filed as: STAMFORD ANDREW · STAMFORD ANDREW W · STAMFORD ANDREW WILLIAM
126 granted patents·33 pending applications·1,086 citations·filing 1994–2023
99Inventor score
Top patents by PatentIndex Score
159 records- 0198US6821978B2Xanthine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2001·Granted Nov 23, 2004·140 cites·34 claims
- 0298US6329395B1Neuropeptide Y5 receptor antagonistsSCHERING CORP·Filed 1999·Granted Dec 11, 2001·186 cites·9 claims
- 0395US8729071B2Iminothiadiazine dioxide compounds as BACE inhibitors, compositions and their useSCOTT JACK D·Filed 2010·Granted May 20, 2014·27 cites·25 claims
- 0495US7763609B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2007·Granted Jul 27, 2010·38 cites·12 claims
- 0594US9156872B22′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Oct 13, 2015·45 cites·21 claims
- 0694US9061041B22′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Jun 23, 2015·49 cites·43 claims
- 0794US8940748B2Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2014·Granted Jan 27, 2015·15 cites·45 claims
- 0893US9029362B2Iminothiadiazine dioxide compounds as brace inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2014·Granted May 12, 2015·13 cites·25 claims
- 0992US6969719B2Polycyclic guanine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2002·Granted Nov 29, 2005·59 cites·26 claims
- 1091US9475785B2Iminothiadiazine dioxide compounds as BACE inhibitors, compositions and their useMERCK SHARP & DOHME·Filed 2015·Granted Oct 25, 2016·8 cites·28 claims
- 1191US9428475B2Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2014·Granted Aug 30, 2016·9 cites·28 claims
- 1291US6894063B2Substituted urea neuropeptide Y Y5 Receptor antagonistsSCHERING CORP·Filed 2002·Granted May 17, 2005·24 cites·17 claims
- 1390US9221839B2C5-C6 oxacyclic-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their useCUMMING JARED N·Filed 2012·Granted Dec 29, 2015·10 cites·12 claims
- 1490US7868000B2Aspartyl protease inhibitorsSCHERING CORP·Filed 2006·Granted Jan 11, 2011·18 cites·45 claims
- 1588US7700603B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2005·Granted Apr 20, 2010·9 cites·8 claims
- 1687US10329289B26,7-dihydro-5H-pyrrolo[3,4-B]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptorBAO JIANMING·Filed 2016·Granted Jun 25, 2019·10 cites·20 claims
- 1787US9150603B22′-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Oct 6, 2015·14 cites·21 claims
- 1887US8563543B2Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their useSCOTT JACK D·Filed 2010·Granted Oct 22, 2013·13 cites·13 claims
- 1987US8183252B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2010·Granted May 22, 2012·8 cites·88 claims
- 2087US7803802B2Substituted amide beta secretase inhibitorsSCHERING CORP·Filed 2005·Granted Sep 28, 2010·5 cites·19 claims
- 2187US7700597B2Substituted piperazines as CB1 antagonistsSCHERING CORP·Filed 2005·Granted Apr 20, 2010·9 cites·50 claims
- 2287US6897217B22-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2004·Granted May 24, 2005·25 cites·21 claims
- 2386US10093683B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 9, 2018·4 cites·13 claims
- 2486US8829036B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Sep 9, 2014·7 cites·3 claims
- 2586US7973067B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2008·Granted Jul 5, 2011·6 cites·22 claims
- 2686US7910590B2Cyclic amine bace-1 inhibitors having a heterocyclic substituentSCHERING CORP·Filed 2009·Granted Mar 22, 2011·8 cites·31 claims
- 2786US6946476B2Heteroaryl urea neuropeptide Y Y5 receptor antagonistsSCHERING CORP·Filed 2002·Granted Sep 20, 2005·16 cites·21 claims
- 2885US8691831B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Apr 8, 2014·7 cites·18 claims
- 2985US8691833B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Apr 8, 2014·7 cites·9 claims
- 3085US8278334B2Cyclic amine BACE-1 inhibitors having a benzamide substituentCUMMING JARED N·Filed 2009·Granted Oct 2, 2012·7 cites·10 claims
- 3185US6667319B2Neuropeptide Y Y5 receptor antagonistsSCHERING PLOUGH CORP·Filed 2002·Granted Dec 23, 2003·22 cites·16 claims
- 3284US8569310B2Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions and their useISERLOH ULRICH·Filed 2010·Granted Oct 29, 2013·10 cites·16 claims
- 3384US7763606B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2006·Granted Jul 27, 2010·5 cites·16 claims
- 3484US7592348B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2004·Granted Sep 22, 2009·16 cites·41 claims
- 3583US10472347B2Aminopyrazine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2015·Granted Nov 12, 2019·5 cites·19 claims
- 3683US8557826B2Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions, and their useSTAMFORD ANDREW W·Filed 2010·Granted Oct 15, 2013·8 cites·11 claims
- 3783US8450331B2Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their useZHU ZHAONING·Filed 2009·Granted May 28, 2013·5 cites·13 claims
- 3883US8012953B2Macrocyclic beta-secretase inhibitorsSCHERING CORP·Filed 2009·Granted Sep 6, 2011·5 cites·30 claims
- 3983US8012960B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2010·Granted Sep 6, 2011·5 cites·19 claims
- 4083US7812013B2Macrocyclic heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2006·Granted Oct 12, 2010·5 cites·12 claims
- 4183US6444687B1Substituted imidazole neuropeptide Y Y5 receptor antagonistsSCHERING CORP·Filed 2000·Granted Sep 3, 2002·18 cites·7 claims
- 4282US8557798B2Macrocyclic heterocyclic aspartyl protease inhibitorsISERLOH ULRICH·Filed 2009·Granted Oct 15, 2013·5 cites·11 claims
- 4382US7560451B2Aspartyl protease inhibitorsSCHERING CORP·Filed 2006·Granted Jul 14, 2009·5 cites·20 claims
- 4481US10011615B2Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist propertiesMERCK SHARP & DOHME·Filed 2017·Granted Jul 3, 2018·3 cites·14 claims
- 4581US7759353B2Substituted spiro iminopyrimidinones as aspartyl protease inhibitors, compositions, and methods of treatmentSCHERING CORP·Filed 2006·Granted Jul 20, 2010·5 cites·14 claims
- 4681US7759354B2Bicyclic guanidine derivatives as asparyl protease inhibitors, compositions, and uses thereofSCHERING CORP·Filed 2006·Granted Jul 20, 2010·5 cites·19 claims
- 4781US7713985B2Adenosine Aa2 receptor antagonistsSCHERING CORP·Filed 2007·Granted May 11, 2010·4 cites·13 claims
- 4881US7531544B2Xanthine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2007·Granted May 12, 2009·2 cites·3 claims
- 4980US7662816B2Cyclic amine BACE-1 inhibitors having a benzamide substituentSCHERING CORP·Filed 2004·Granted Feb 16, 2010·11 cites·25 claims
- 5080US7459450B2Neuropeptide receptor modulatorsSCHERING CORP·Filed 2005·Granted Dec 2, 2008·5 cites·29 claims
Showing the top 50 of 159 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →